Rhythm Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Alternative corporations in the rating industry group for Rhythm Pharmaceuticals Inc are displayedin the table. The ESG assessment for Rhythm Pharmaceuticals Inc represents its transparency towards the UN SDGs. If you are employed by Rhythm Pharmaceuticals Inc and you wish to licence your ESG rating, please contact us.
Rhythm Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.3; made up of an environmental score of 6.0, social score of 8.0 and governance score of 4.8.
6.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 402 | United Laboratories International Holdings Ltd | 6.4 | High |
| 402 | Zenabis Global Inc | 6.4 | High |
| 427 | Rhythm Pharmaceuticals Inc | 6.3 | High |
| 427 | Calliditas Therapeutics AB | 6.3 | High |
| 427 | Carna Biosciences Inc | 6.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Rhythm Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Rhythm Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Rhythm Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Rhythm Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Rhythm Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Rhythm Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Rhythm Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is also developing setmelanotide, which is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. Rhythm Pharmaceuticals, Inc. has a collaborative research agreement with the Clinical Registry Investigating Bardet-Biedl Syndrome. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.